Candel Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Candel Therapeutics | 10-Q: Q2 2024 Earnings Report
Candel Therapeutics | 8-K: Candel Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
Candel Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Tyagarajan Seshu
Candel Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Tak Paul Peter
Candel Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Schoch Charles
Candel Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Nichols William Garrett
Candel Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Barone Francesca
Candel Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Candel Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Candel Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Candel Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Candel Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Candel Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Tyagarajan Seshu
Candel Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Tak Paul Peter
Candel Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Schoch Charles
Candel Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Nichols William Garrett
Candel Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Barone Francesca
Candel Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Candel Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
No Data
No Data